PMVP · Company research
PMV Pharmaceuticals, Inc (PMVP): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
15records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| PMVP Stock Rises 19% in 3 Months: Here's What You Need to Know - Yahoo Finance | PMVP Stock Rises 19% in 3 Months: Here's What You Need to Know Yahoo Finance | View source ↗ | Yahoo Finance | Oct 12, 2026 | neutral | 0 | 0.6 |
| PMVP Stock Rises 19% in 3 Months: Here's What You Need to Know | PMV Pharmaceuticals (PMVP) has gained nearly 19% in three months following encouraging clinical data for its lead drug rezatapopt, which achieved a 46% response rate in ovarian cancer patients. The company plans to submit an NDA in Q1 2027 and raised $50.8 million through a public offering to fund operations into Q1 2028. | View source ↗ | Zacks Investment Research | Oct 12, 2026 | bullish | 0.4 | 1 |
| Pmv Pharmaceuticals Inc (NASDAQ: PMVP) Share Price, PMVP Stock News, PMVP Share Price & Updates - Kalkine | Pmv Pharmaceuticals Inc (NASDAQ: PMVP) Share Price, PMVP Stock News, PMVP Share Price & Updates Kalkine | View source ↗ | Kalkine | Oct 9, 2026 | neutral | 0 | 0.6 |
| A Q1 2027 application for accelerated approval is planned for PMV’s ovarian cancer drug. - Stock Titan | A Q1 2027 application for accelerated approval is planned for PMV’s ovarian cancer drug. Stock Titan | View source ↗ | Stock Titan | Oct 5, 2026 | neutral | 0 | 0.6 |
| Phase 2 single-drug enrollment is complete. PMV Pharma (PMVP) plans an ovarian cancer drug application. - Stock Titan | Phase 2 single-drug enrollment is complete. PMV Pharma (PMVP) plans an ovarian cancer drug application. Stock Titan | View source ↗ | Stock Titan | Oct 5, 2026 | neutral | 0 | 0.6 |
| Biotech Stocks At 52-Week Highs - KOD, MASS, OBIO, CDNA, PMVP - RTTNews | Biotech Stocks At 52-Week Highs - KOD, MASS, OBIO, CDNA, PMVP RTTNews | View source ↗ | RTTNews | Oct 2, 2026 | neutral | 0 | 0.6 |
| Should You Buy PMV Pharmaceuticals, Inc. (PMVP) After Golden Cross? - Yahoo Finance | Should You Buy PMV Pharmaceuticals, Inc. (PMVP) After Golden Cross? Yahoo Finance | View source ↗ | Yahoo Finance | Sep 16, 2026 | neutral | 0 | 0.6 |
| An investor group in PMV Pharmaceuticals (NASDAQ: PMVP) is held just under a 10% stake by its warrant terms. - Stock Titan | An investor group in PMV Pharmaceuticals (NASDAQ: PMVP) is held just under a 10% stake by its warrant terms. Stock Titan | View source ↗ | Stock Titan | Sep 15, 2026 | neutral | 0 | 0.6 |
| What's Going On With PMV Pharmaceuticals Stock Tuesday? - PMV Pharmaceuticals (NASDAQ:PMVP) - Benzinga | What's Going On With PMV Pharmaceuticals Stock Tuesday? - PMV Pharmaceuticals (NASDAQ:PMVP) Benzinga | View source ↗ | Benzinga | Sep 1, 2026 | neutral | 0 | 0.6 |
| Ovarian cancer trial reports a 46% response rate; FDA filing planned - Stock Titan | Ovarian cancer trial reports a 46% response rate; FDA filing planned Stock Titan | View source ↗ | Stock Titan | Aug 31, 2026 | neutral | 0 | 0.6 |
| PMV (PMVP) Watch: Moves 1.15% Higher to $1.31; Price Context: Price Remains Between $1.24 Support and $1.38 Resistance in the Latest Session - Algorithmic Stock Picks - dars.gov.et | PMV (PMVP) Watch: Moves 1.15% Higher to $1.31; Price Context: Price Remains Between $1.24 Support and $1.38 Resistance in the Latest Session - Algorithmic Stock Picks dars.gov.et | View source ↗ | dars.gov.et | Aug 21, 2026 | neutral | 0 | 0.6 |
| PMVP Forecast — Price Target — Prediction for 2027 - TradingView | PMVP Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 25, 2026 | neutral | 0 | 0.6 |
| PMV Pharmaceuticals (PMVP) Upgraded to Buy: Here's Why - Yahoo Finance | PMV Pharmaceuticals (PMVP) Upgraded to Buy: Here's Why Yahoo Finance | View source ↗ | Yahoo Finance | Jun 24, 2026 | neutral | 0 | 0.6 |
| PMV Pharmaceuticals (PMVP) Loses 26% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance | PMV Pharmaceuticals (PMVP) Loses 26% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner Yahoo Finance | View source ↗ | Yahoo Finance | Jun 10, 2026 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | Mar 26, 2024 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.